We are a team of passionate experimental biologists, physician-scientists, and bioinformaticians driving progress in cancer research combining our expertise in cell and molecular biology, immunology, computer and translational science. Together, we are uncovering new insights into cancer and its interaction with the immune system to drive transformative new therapies that enhance patient care.
Gregory J. Baker, PhD, PharmD
Principal Investigator
Greg established his laboratory at the OHSU Knight Cancer Institute in 2025 to focus on early cancer detection and interception. He completed postdoctoral training in computational and systems biology with Peter Sorger at Harvard Medical School in 2021 where he developed software programs for biomedical research. Before that, Greg earned his PhD in translational brain tumor immunology with Pedro Lowenstein and Maria Castro at UCLA in 2014. He also holds a Doctorate in Pharmacy (PharmD) from the University of Rhode Island, which he received in 2007. In his free time, Greg enjoys playing electric guitar and writing and listening to music.
Click here to view our alumni page.